drugset
drugset / Trial / NCT04335266

A Food Effect Study of SHR2554 on Healthy Chinese Male Adult Subjects

NCT04335266 ↗

Phase 1 Completed 20 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedCrossoverOpen-labelBasic science

Summary

The primary objective of the study is to evaluate the effect of high-fat diet on pharmacokinetics of healthy Chinese male adult subjects after oral administration of SHR2554 tablets. The secondary objective of the study is to evaluate the safety of single dose of SHR2554 orally in healthy subjects.

Timeline

Start
2019-08-06
Primary completion
2019-09-09
Completion
2020-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR2554 Small molecule — Oral

Indications

No indication recorded.